Concurrent deletion of 16q23 and PTEN is an independent prognostic feature in prostate cancer.
Kluth M, Runte F, Barow P, Omari J, Abdelaziz ZM, Paustian L, Steurer S, Christina Tsourlakis M, Fisch M, Graefen M, Tennstedt P, Huland H, Michl U, Minner S, Sauter G, Simon R, Adam M, Schlomm T.
Kluth M, et al. Among authors: schlomm t.
Int J Cancer. 2015 Nov 15;137(10):2354-63. doi: 10.1002/ijc.29613. Epub 2015 Jun 4.
Int J Cancer. 2015.
PMID: 26009879
Free article.